Recent epidemiological data indicates a substantial reduction in cervical cancer mortality among women who received the HPV vaccine during early adolescence.

最近的流行病學數據顯示，在青春期早期接種 HPV 疫苗的女性，子宮頸癌死亡率大幅下降。

The longitudinal efficacy of the HPV vaccination program, initiated for girls aged 12–13 in 2008, is evidenced by a near-total elimination of cervical cancer deaths in the 20–24 age cohort between 2020 and 2024. Statistical modeling suggests that in the absence of immunization, approximately 23 fatalities would have occurred during this interval. Furthermore, a 63% reduction in the relative risk of death is observed among vaccinated women aged 30–34 compared to non-vaccinated counterparts. These outcomes are attributed to the vaccine's ability to prevent infections from the human papillomavirus, which is identified as the causative agent in 99% of cervical cancer cases.

2008年開始針對12至13歲女孩的 HPV 疫苗接種計劃，其長期療效顯著，證據在於 2020 年至 2024 年間，20至24歲年齡組別幾乎完全消除了子宮頸癌死亡個案。統計模型顯示，若無接種疫苗，該期間大約將有 23 人死亡。此外，與未接種者相比，30至34歲接種疫苗的女性死亡相對風險降低了 63%。這些成果歸功於疫苗能防止人類乳頭瘤病毒感染，而該病毒被認定為 99% 子宮頸癌個案的致病原。

Despite these clinical advancements, institutional challenges persist regarding immunization coverage. Current data from the UK Health Security Agency indicates a vaccination rate of 76% for girls by age 15, a figure that falls short of the 90% threshold established by the World Health Organization for the elimination of the disease. This decline in uptake, particularly noted post-pandemic, has prompted the Department of Health and Social Care to implement remedial measures, including the deployment of catch-up campaigns via community pharmacies and the distribution of self-testing kits for screening.

儘管有這些臨床進展，但在接種覆蓋率方面仍面臨制度性挑戰。英國健康安全局的現有數據顯示，15 歲前女孩的接種率為 76%，低於世界衛生組織為消滅該疾病而設定的 90% 門檻。接種率的下降（尤其在疫情後），促使衛生及社會關懷部採取補救措施，包括透過社區藥局推行補種計劃，以及分發篩查自我檢測套件。

Broadening the scope of the public health strategy, the vaccine was extended to boys in 2019 to mitigate the incidence of various anogenital and oropharyngeal malignancies and to reduce viral transmission. While the UK government maintains a target of eliminating cervical cancer as a public health concern by 2040, the continued necessity of cervical screenings for women aged 25–64 remains a critical component of the diagnostic framework.

為擴大公共衛生策略範圍，疫苗於 2019 年延伸至男孩，以降低各種生殖器及口咽癌的發生率並減少病毒傳播。雖然英國政府目標是在 2040 年前將子宮頸癌從公共衛生問題中消滅，但 25 至 64 歲女性持續進行子宮頸篩查，依然是診斷框架中至關重要的組成部分。

While the HPV vaccine has demonstrably reduced mortality, achieving total elimination requires an increase in vaccination rates to meet international benchmarks.

雖然 HPV 疫苗已證明能降低死亡率，但要實現完全消滅，仍需提高接種率以符合國際基準。